Vestal Point Capital »

United Therapeutics Corporation shares owned by Vestal Point Capital

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $45M 75k 592.98

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
Renaissance Technologies
State Street Corporation
Geode Capital Management
Henderson Group
AQR Capital Management
Citadel Advisors
Assetmark
Invesco
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation